drug policy and regulation
Are psychedelics actually medicine?: The Story
The vote that sank a revolution August 2024. The FDA rejected MDMA-assisted therapy for PTSD. Lykos Therapeutics — formerly MAPS, a nonprofit that spent $135 million and three decades getting MDMA through trials — watched its Phase 3 data sink....